Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lopinavir/Ritonavir”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01159275
What this trial is testing

Lopinavir (LPV) Dose Reduction

Who this might be right for
HIV-1 Infections
The HIV Netherlands Australia Thailand Research Collaboration 20
Testing effectiveness (Phase 2)Study completedNCT00125983
What this trial is testing

Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 32
Post-approval studies (Phase 4)Study completedNCT04487145
What this trial is testing

Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy

Who this might be right for
Drug-Drug InteractionHIV Infection
University of California, San Francisco 194
Large-scale testing (Phase 3)Study completedNCT04466241
What this trial is testing

Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial

Who this might be right for
COVID-19COVID-19 Drug TreatmentSevere Acute Respiratory Syndrome Coronavirus 2
ANRS, Emerging Infectious Diseases 294
Post-approval studies (Phase 4)Ended earlyNCT01700790
What this trial is testing

Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin

Who this might be right for
AIDSTuberculosis
University of Miami 9
Post-approval studies (Phase 4)Study completedNCT01189695
What this trial is testing

Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure

Who this might be right for
HIVAIDSLopinavir+1 more
Bamrasnaradura Infectious Diseases Institute 63
Large-scale testing (Phase 3)Study completedNCT00050895
What this trial is testing

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 775
Testing effectiveness (Phase 2)Study completedNCT00038532
What this trial is testing

Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART

Who this might be right for
HIV Infections
Abbott 24
Testing effectiveness (Phase 2)Ended earlyNCT00144105
What this trial is testing

A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients.

Who this might be right for
HIV Infections
Boehringer Ingelheim 562
Not applicableStudy completedNCT01076985
What this trial is testing

Special Investigation of Kaletra in Pregnant Women

Who this might be right for
Human Immunodeficiency Virus
Abbott 24
Early research (Phase 1)Study completedNCT00723775
What this trial is testing

GSK706769/KALETRA Drug-drug Interaction Study

Who this might be right for
Infection, Human Immunodeficiency Virus
GlaxoSmithKline 17
Not applicableStudy completedNCT01379703
What this trial is testing

Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use

Who this might be right for
HIV-1 Patients
Abbott 2,288
Large-scale testing (Phase 3)Study completedNCT00234923
What this trial is testing

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients

Who this might be right for
HIV Infection
Abbott 138
Large-scale testing (Phase 3)Study completedNCT00105079
What this trial is testing

GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection

Who this might be right for
HIV Infections
Hoffmann-La Roche 337
Early research (Phase 1)Study completedNCT01671982
What this trial is testing

ALternative TEnofovir Dosing in Adults With Moderate Renal Function Impairment

Who this might be right for
HIV
Institut de Recherche pour le Developpement 40
Post-approval studies (Phase 4)UnknownNCT04255017
What this trial is testing

A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia

Who this might be right for
2019-nCoV
Tongji Hospital 400
Large-scale testing (Phase 3)Study completedNCT00086359
What this trial is testing

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 19
Testing effectiveness (Phase 2)Study completedNCT01139905
What this trial is testing

Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children

Who this might be right for
HIV-1 Infections
The HIV Netherlands Australia Thailand Research Collaboration 24
Post-approval studies (Phase 4)Study completedNCT00772902
What this trial is testing

ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial

Who this might be right for
HIV-1
Gilead Sciences 85
Testing effectiveness (Phase 2)Study completedNCT01138202
What this trial is testing

Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy

Who this might be right for
HIV InfectionsTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 40
Next Page